B-cell Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for B-cell Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2019-05-10EMA Withdrawn: Arzerra (ofatumumab) — Novartis Europharm Ltd
EMA has withdrawn Arzerra (ofatumumab) from the market in Europe.